image
CNS Pharmaceuticals, Inc. CNSP
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 0.1051
-11.6 %
$ 3.9 M
Market Cap
0.0
P/E
FINANCIAL REPORTS

Reports

Report Date Revenue YoY Net Income YoY Operating Income YoY View
Annual Report FY 10-K 2023-12-31 0.00% -23.42% -23.57%
Annual Report FY 10-K 2022-12-31 0.00% -5.37% -8.84%
Annual Report FY 10-K 2021-12-31 0.00% -53.26% -48.36%
Annual Report FY 10-K 2020-12-31 0.00% -143.93% -146.66%
Annual Report FY 10-K 2019-12-31 0.00% 47.55% -334.68%
Annual Report FY 10-K 2018-12-31 0.00% -1304.05% -309.94%
Annual Report FY 10-K 2017-12-31 0.00% 0.00% 0.00%
Quarterly Report Q3 8-K 2024-09-30 0.00% -23.95% -24.15%
Quarterly Report Q2 8-K 2024-06-30 0.00% 37.07% 37.20%
Quarterly Report Q1 8-K 2024-03-31 0.00% 28.13% 28.05%
Quarterly Report Q4 8-K 2023-12-31 0.00% -4.64% 2.23%
Quarterly Report Q3 8-K 2023-09-30 0.00% -32.26% -32.61%
Quarterly Report Q2 8-K 2023-06-30 0.00% -12.77% -12.93%
Quarterly Report Q1 8-K 2023-03-31 0.00% -56.48% -77.10%
Quarterly Report Q4 8-K 2022-12-31 0.00% -57.87% -97.00%
Quarterly Report Q3 8-K 2022-09-30 0.00% 10.35% 10.34%
Quarterly Report Q2 8-K 2022-06-30 0.00% 6.50% 6.48%
Quarterly Report Q1 8-K 2022-03-31 0.00% 12.78% 22.94%
Quarterly Report Q4 8-K 2021-12-31 0.00% -8.28% 6.95%
Quarterly Report Q3 8-K 2021-09-30 0.00% -89.67% -89.62%
Quarterly Report Q2 8-K 2021-06-30 0.00% -54.16% -54.07%
Quarterly Report Q1 8-K 2021-03-31 0.00% -83.60% -83.41%
Quarterly Report Q4 8-K 2020-12-31 0.00% -18.90% -18.94%
Quarterly Report Q3 8-K 2020-09-30 0.00% -184.59% -187.67%
Quarterly Report Q2 8-K 2020-06-30 0.00% -473.02% -496.00%
Quarterly Report Q1 8-K 2020-03-31 0.00% -830.55% -908.83%
Quarterly Report Q4 8-K 2019-12-31 0.00% 61.89% -1109.94%
Quarterly Report Q3 8-K 2019-09-30 0.00% -265.76% -311.46%
Quarterly Report Q2 8-K 2019-06-30 0.00% -67.66% -111.12%
Quarterly Report Q1 8-K 2019-03-31 0.00% 31.71% 36.39%
Quarterly Report Q4 8-K 2018-12-31 0.00% 0.00% 0.00%
Quarterly Report Q3 8-K 2018-09-30 0.00% 0.00% 0.00%
Quarterly Report Q2 8-K 2018-06-30 0.00% 0.00% 0.00%
Quarterly Report Q1 8-K 2018-03-31 0.00% 0.00% 0.00%